Our studies suggest that Uev1A promotes cell survival under serum starvation stress through the AKT-FOXO1-BIM axis in breast cancer cells, and identified a potential therapeutic target in the treatment of both triple negative and estrogen receptor positive breast cancers. This evidence concerns the gene AKT1 and breast cancer.